Senator Mike Crapo @MikeCrapo
The Biden Administration’s decision to restrict Medicare coverage for current and future FDA-approved Alzheimer’s treatments is a disturbing break from precedent that risks chilling innovation and jeopardizing access to new treatments. — PolitiTweet.org